Clinical Trial Update: Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study

View source ↗

Summary

Update on long-term clinical outcomes for subjects enrolled in the RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) new enrollment study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphakia
• Cataract

Drugs mentioned

• Light Adjustable Lens (LAL) (Light Adjustable Lens)
• Light Delivery Device (LDD)

Snippet

Sponsor: RxSight, Inc. | Conditions: Aphakia Cataract | Status: ENROLLING_BY_INVITATION